Clinical Trial Update: Molecular Markers in Cancers and Precancers (MOCA) [NA]

View source ↗

Summary

The MOCA trial (NCT05257707) investigating molecular markers in cancers and precancerous lesions has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Precancerous Lesion

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Cancer, Precancerous Lesion | NA | Status: WITHDRAWN